-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Whole exome sequencing and RNA-seq of esophageal squamous cell carcinoma
Study
JGAS000367
-
intratumor heterogeneity in colorectal adenoma and carcinoma
Study
JGAS000092
-
Genome-wide copy number analysis of neuroblastoma
Study
JGAS000046
-
Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface
Study
JGAS000073
-
Whole-genome sequencing of the parental tumor and established organoids from a patient with gastric-type cervical adenocarcinoma
Study
JGAS000796
-
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas
Study
JGAS000022
-
DNA methylation at HBV integrants and flanking host genomes
Study
JGAS000015
-
Unraveling the heterogeneity of multiple myeloma identifies therapy resistant subpopulation with vulnerability to the splicing pathway intervention
Study
JGAS000723
-
Durable clinical impacts and mechanisms of action and resistance in histone K27 methylation-targeting epigenetic therapy
Study
JGAS000553
-
Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs
Study
JGAS000057
-
Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Study
JGAS000226
-
Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors
Study
JGAS000868
-
DNA demethylation is associated with malignant progression of low-grade gliomas
Study
JGAS000146
-
1. Identidication of molecular biological mechanism associated with the development and prognosis of uterine cancer, uterine sarcoma, and endometrial hyperplasia / 2. Identification of molecular biological mechanism associated with the development of endometriosis and malignant transformation, ovarian cancer, fallopian tubal cancer, peritoneal cancer, and other malignant tumors in gynecological organs
Study
JGAS000789
-
Whole genome sequencing, single-cell RNA sequencing, and ATAC sequencing of mesothelioma (patient, patient-derived xenograft and cell line)
Study
JGAS000859
-
Sequencing cancer mutations in various types of lung cancer using the long-read, portable sequencer
Study
JGAS000065
-
Exploratory novel biomarker and resistance mechanism of milademetan, an MDM2 inhibitor, in MDM2 amplified intimal sarcoma from an open-label phase 1b/2 trial ���NCCH1806/MK004���
Study
JGAS000619
-
Whole exome sequencing and RNA sequencing of myxoid liposarcoma patients
Study
JGAS000768
-
Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface
Study
JGAS000107
-
Spatial transcriptomics of epithelial-mesenchymal transition in uterine carcinosarcoma
Study
JGAS000964
-
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Study
JGAS000622
-
Establishing stable brain tumor stem cell lines and translational research for new treatments
Study
JGAS000657
-
Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis thymoma
Study
JGAS000672
-
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance
Study
JGAS000004
-
Target sequencing of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in Japanese renal cell carcinoma patients
Study
JGAS000414
-
Identification and Characterization of Cancer Mutations in Japanese LungAdenocarcinoma without Sequencing of Normal Tissue Counterparts
Study
JGAS000001
-
Paediatric Hepatic International Tumour Trial (JPLT2: PHITT)
Study
JGAS000236
-
Comprehensive molecular and clinicopathological profiling of lung adenocarcinoma in Japanese never or light smokers
Study
JGAS000215
-
Genomic subtypes and cellular phenotypes of high-grade endometrial carcinoma
Study
JGAS000753
-
snRNA-seq on follicular lymphoma
Dataset
EGAD50000002988
-
transcriptomics for CRCS-CRC1 cohort
Dataset
EGAD50000003131
-
Variant calling for CRCS-CRC1 cohort
Dataset
EGAD50000003132
-
use of Darovasertib in uveal melanoma
Study
EGAS50000002241
-
Lynch syndrome adenoma and carcinoma samples
Study
EGAS50000001920
-
Lynch Syndrome Adenoma Whole Genome Sequencing Dataset from Maruvka Laboratory
Dataset
EGAD50000002790
-
uveal melanoma WGS data
Dataset
EGAD50000003224
-
Investigating adaptive immune responses in MM patients treated with belantamab mafodotin
Study
EGAS50000001889
-
Identification of broadly tumor-reactive γδ TCRs from multiple myeloma
Study
EGAS50000001888
-
Targeted methylation profiling identifies distinct tissue-derived and plasma-derived signatures in pancreatic ductal adenocarcinoma - B135-methylation
Study
EGAS50000002245
-
Targeted methylation profiling of tissue and plasma samples of pancreatic ductal adenocarcinoma patients.
Dataset
EGAD50000003228
-
Institut Imagine-Paris-France-Lymphoma
Dac
EGAC50000000951
-
Methylproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007342
-
Total proteome and phosphoproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007341
-
Whole-genome sequencing of cell-free DNA from pancreatic and breast cancer cohorts for fragmentomic and tumor fraction analysis
Study
EGAS50000001620
-
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient
Study
EGAS50000000102
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000803
-
Parkinson's Disease and Melanoma: Mechanistically Linked via L-DOPA Treatment and Pheomelanin Carcinogenicity
Study
phs004726
-
Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer
Study
phs004909
-
Tumorigenic DICER1 mutations rewire miRNA circuitry to stabilize pro-growth mRNAs and degrade pro-apoptotic mRNAs
Study
EGAS50000001694